Subcutaneous boosting with heparin binding haemagglutinin increases BCG-induced protection against tuberculosis

Microbes and Infection

Volumn 11, Issue 13, 2009, Pages 995-1001

  Rouanet, Carine ^a,b   Debrie, Anne Sophie ^a,b   Lecher, Sophie ^a,b   Locht, Camille ^a,b  

^a INSERM   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Boost; HBHA; Tuberculosis; Vaccination

Indexed keywords

BACTERIUM ANTIBODY; BCG VACCINE; GAMMA INTERFERON; HEMAGGLUTININ; HEPARIN BINDING HEMAGGLUTININ; INTERLEUKIN 5; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BCG VACCINATION; CELLULAR IMMUNITY; CLINICAL PROTOCOL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMORAL IMMUNITY; LUNG TUBERCULOSIS; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTECTION; TH1 CELL; TH2 CELL;

ANIMALS; BACTERIAL PROTEINS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; IMMUNIZATION, SECONDARY; INTERFERON-GAMMA; INTERLEUKIN-5; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MYCOBACTERIUM BOVIS; SPLEEN; STATISTICS, NONPARAMETRIC; TUBERCULOSIS; TUBERCULOSIS VACCINES;

MUS; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

EID: 70349759312     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2009.07.005     Document Type: Article

References (21)

1. Tuberculosis fact sheet no. 104. World Health Organisation.
2. Colditz G.A., Brewer T.F., Berkey C.S., Wilson M.E., Burdick E., Fineberg H.V., and Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. J. Am. Med. Assoc. 271 (1994) 698-702
3. Fine P.E. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346 (1995) 1339-1345
4. Brewer T.F. Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature. Clin. Infect. Dis. 31 Suppl. 3 (2000) S64-S67
5. Karonga Prevention Trial Group. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet 348 (1996) 17-24
6. Rodrigues L.C., Pereira S.M., Cunha S.S., Genser B., Ichihara M.Y., De Brito S.C., Hijjar M.A., Dourado I., Cruz A.A., Sant'Anna C., Bierrenbach A.L., and Barreto M.L. Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial. Lancet 366 (2005) 1290-1295
7. Basaraba R.J., Izzo A.A., Brandt L., and Orme I.M. Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations. Vaccine 24 (2006) 280-286
8. Menozzi F.D., Rouse J.H., Alavi M., Laude-Sharp M., Muller J., Bischoff R., Brennan M.J., and Locht C. Identification of a heparin-binding hemagglutinin present in mycobacteria. J. Exp. Med. 184 (1996) 993-1001
9. Reddy V.M., and Kumar B. Interaction of Mycobacterium avium complex with human respiratory epithelial cells. J. Infect. Dis. 181 (2000) 1189-1193
10. Sechi L.A., Ahmed N., Felis G.E., Dupre I., Cannas S., Fadda G., Bua A., and Zanetti S. Immunogenicity and cytoadherence of recombinant heparin binding haemagglutinin (HBHA) of Mycobacterium avium subsp. paratuberculosis: functional promiscuity or a role in virulence?. Vaccine 24 (2006) 236-243
11. Biet F., Angela de Melo Marques M., Grayon M., Xavier Da Silveira E.K., Brennan P.J., Drobecq H., Raze D., Vidal Pessolani M.C., Locht C., and Menozzi F.D. Mycobacterium smegmatis produces an HBHA homologue which is not involved in epithelial adherence. Microbes Infect 9 (2007) 175-182
12. Locht C., Raze D., Rouanet C., Génisset C., Segers J., and Mascart F. The mycobacterial heparin-binding hemagglutinin: a virulence factor and antigen useful for diagnostics and vaccine development. In: Daffé M., and Reyrat J.M. (Eds). The Mycobacterial Cell Envelope (2008), ASM Press, Washington, DC 305-322
13. Pethe K., Alonso S., Biet F., Delogu G., Brennan M.J., Locht C., and Menozzi F.D. The heparin-binding haemagglutinin of Mycobacterium tuberculosis is required for extrapulmonary dissemination. Nature 412 (2001) 190-194
14. Masungi C., Temmerman S., Van Vooren J.P., Drowart A., Pethe K., Menozzi F.D., Locht C., and Mascart F. Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis. J. Infect. Dis. 185 (2002) 513-520
15. Temmerman S., Pethe K., Parra M., Alonso S., Rouanet C., Pickett T., Drowart A., Debrie A.S., Delogu G., Menozzi F.D., Sergheraert C., Brennan M.J., Mascart F., and Locht C. Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin. Nat. Med. 10 (2004) 935-941
16. Parra M., Pickett T., Delogu G., Dheenadhayalan V., Debrie A.S., Locht C., and Brennan M.J. The mycobacterial heparin-binding hemagglutinin is a protective antigen in the mouse aerosol challenge model of tuberculosis. Infect. Immun. 72 (2004) 6799-6805
17. Sauton B. Sur la nutrition minérale du bacille tuberculeux. C.R. Acad. Sci. Ser. III Sci. Vie. 155 (1912) 860-863
18. Kohama H., Umemura M., Okamoto Y., Yahagi A., Goga H., Harakuni T., Matsuzaki G., and Arakawa T. Mucosal immunisation with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice. Vaccine 26 (2008) 924-932
19. Dietrich J., Andersen C., Rappuoli R., Doherty T.M., Green Jensen C., and Andersen P. Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boost prior bacillus Calmette-Guérin immunity. J. Immunol. 177 (2006) 6353-6360
20. Reed S.G., Coler R.N., Dalemans W., Tan E.V., DeLa Cruz E.C., Basaraba R.J., Orme I.M., Skeiky Y.A., Alderson M.R., Cowgill K.D., Prieels J.P., Abalos R.M., Dubois M.C., Cohen J., Mettens P., and Lobet Y. Defined tuberculosis vaccine, Mtb72F/ASO2A, evidence of protection in cynomolgus monkeys. Proc. Natl. Acad. Sci. USA, 106 (2009) 2301-2306
21. Gupta U.D., Katoch V.M., and McMurray D.N. Current status of TB vaccines. Vaccine 25 (2007) 3742-3751